These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1939959)
1. Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome. Gomez-Sanchez MA; Saenz de la Calzada C; Gomez-Pajuelo C; Martinez-Tello FJ; Mestre de Juan MJ; James TN J Am Coll Cardiol; 1991 Nov; 18(6):1539-45. PubMed ID: 1939959 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension due to toxic oil syndrome. A clinicopathologic study. Gómez-Sánchez MA; Mestre de Juan MJ; Gómez-Pajuelo C; López JI; Díaz de Atauri MJ; Martínez-Tello FJ Chest; 1989 Feb; 95(2):325-31. PubMed ID: 2914483 [TBL] [Abstract][Full Text] [Related]
3. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Alonso-Ruiz A; Calabozo M; Perez-Ruiz F; Mancebo L Medicine (Baltimore); 1993 Sep; 72(5):285-95. PubMed ID: 8412642 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome. Cheng TO Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987 [No Abstract] [Full Text] [Related]
5. [Pulmonary hypertension during exercise in toxic oil syndrome]. Tello de Meneses R; Gómez de la Cámara A; Nogales-Morán MA; Escribano-Subías P; Barainca-Oyagüe MT; Gómez-Sánchez MA; Izquierdo-Martínez M; Sáenz de la Calzada C Med Clin (Barc); 2005 Nov; 125(18):685-8. PubMed ID: 16324479 [TBL] [Abstract][Full Text] [Related]
6. The toxic oil syndrome. James TN Clin Cardiol; 1994 Sep; 17(9):463-70. PubMed ID: 8001309 [TBL] [Abstract][Full Text] [Related]
7. An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain. Garcia-Dorado D; Miller DD; Garcia EJ; Delcan JL; Maroto E; Chaitman BR J Am Coll Cardiol; 1983 May; 1(5):1216-22. PubMed ID: 6833663 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension after toxic rapeseed oil ingestion. Castro García M; Posada de la Paz M; Díaz de Rojas F; Abaitua Borda I; Alonso Gordo JM; Tabuenca Oliver JM J Am Coll Cardiol; 1984 Aug; 4(2):443. PubMed ID: 6549605 [No Abstract] [Full Text] [Related]
9. Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases. Phelps RG; Fleischmajer R J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):313-24. PubMed ID: 3279088 [TBL] [Abstract][Full Text] [Related]
10. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734 [TBL] [Abstract][Full Text] [Related]
12. Histologic abnormalities of large and small coronary arteries, neural structures, and the conduction system of the heart found in postmortem studies of individuals dying from the toxic oil syndrome. James TN; Posada-de la Paz M; Abaitua-Borda I; Gomez-Sanchez MA; Martinez-Tello FJ; Soldevilla LB Am Heart J; 1991 Mar; 121(3 Pt 1):803-15. PubMed ID: 2000747 [TBL] [Abstract][Full Text] [Related]
14. Late cases of toxic oil syndrome: evidence that the aetiological agent persisted in oil stored for up to one year. Posada de la Paz M; Abaitua Borda I; Kilbourne EM; Tabuenca Oliver JM; Diaz de Rojas F; Castro Garcia M Food Chem Toxicol; 1989 Aug; 27(8):517-21. PubMed ID: 2792975 [TBL] [Abstract][Full Text] [Related]
15. The association of oil ingestion with toxic oil syndrome in two convents. Diaz de Rojas F; Castro García M; Abaitua Borda I; Alonso Gordo JM; Posada de la Paz M; Kilbourne EM; Tabuenca Oliver JM Am J Epidemiol; 1987 May; 125(5):907-11. PubMed ID: 3565366 [TBL] [Abstract][Full Text] [Related]
16. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism. del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654 [TBL] [Abstract][Full Text] [Related]
17. Toxic oil syndrome: the perspective after 20 years. Posada de la Paz M; Philen RM; Borda AI Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735 [TBL] [Abstract][Full Text] [Related]
18. Severe pulmonary arterial hypertension due to toxic oil syndrome: a new cause of plexogenic arteriopathy. Mestre de Juan MJ; Martinez Tello FJ; Gomez Pajuelo C; Saenz de la Calzada C; Moya Mur JL; Tascon Perez JC; Lombera Romero F; Gomez Sanchez MA Cor Vasa; 1990; 32(3):218-24. PubMed ID: 2209024 [TBL] [Abstract][Full Text] [Related]
19. Cardiac abnormalities in the toxic oil syndrome, with comparative observations on the eosinophilia-myalgia syndrome. James TN; Gómez-Sánchez MA; Martínez-Tello FJ; Posada-de la Paz M; Abaitua-Borda I; Soldevilla LB J Am Coll Cardiol; 1991 Nov; 18(5):1367-79. PubMed ID: 1918715 [TBL] [Abstract][Full Text] [Related]
20. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic. Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]